Author

Relja Popovic

AbbVie (United States)ORCID 0000-0002-6880-0798Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam E. Ziemann· 1 shared Adam PlattiD· 1 shared Aino‐Kaisa PiironeniD· 1 shared Aki Samuli HavulinnaiD· 1 shared Ali AbbasiiD· 1 shared Anastasia Kytölä· 1 shared Andrea GannaiD· 1 shared Anlu CheniD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adam E. Ziemann

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Lipid composition differentiates ferroptosis sensitivity between in vitro and in vivo systems

Vivian S. Park, Lauren E. Pope, Justin P. Ingram, Grace A. Alchemy, Julie J. Purkal, Magdalena B. Murray, Sha Jin, Eli Y. Andino-Frydman, Sanjana Singh, Anlu Chen, Priya Narayanan, Sarah Kongpachith, Darren C. Phillips, Scott J. Dixon, Relja Popovic

This study shows that GPX4 inhibitor sensitivity differs between 2D and 3D cultures due to lipid composition changes, with 3D cultures showing resistance through PUFA displacement by MUFAs.

Cancer Research · Sep 5, 2025Peer-reviewedCancer Biology

A FinnGen pilot clinical recall study for Alzheimer's disease

Valtteri Julkunen, Claudia Schwarz, Juho Kalapudas, Merja Hallikainen, Aino‐Kaisa Piironen, Arto Mannermaa, Hanna Kujala, T. Laitinen, Veli‐Matti Kosma, Teemu I. Paajanen, Reetta K. Kälviäinen, Mikko Hiltunen, Sanna‐Kaisa Herukka, Sari Kärkkäinen, Tarja Kokkola, , Zhihao Ding

The paper demonstrates the feasibility of conducting clinical recall studies from the FinnGen biobank to collect customized clinical data from participants with Alzheimer's disease or mild cognitive disorder.

Scientific Reports · Aug 3, 2023Peer-reviewedGenetic & Genomic Medicine